Metraipolis › archive › dc_51430e40d02f

Risk factors and effectiveness of vaccination for nosocomial SARS-CoV-2 acquisition throughout the SARS-CoV-2 pandemic — Europe PMC PMID:40830930

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40830930
DOI
10.1186/s12879-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-10T12:38:52.429Z
SHA-256 of the archived text
32f15b1ed42768abcb5d3bfc2006350ff680b6d0566b556b9cddc94de225ecb3
Stable URL of this page
https://metraipolis.com/documento/dc_51430e40d02f

How to cite

Risk factors and effectiveness of vaccination for nosocomial SARS-CoV-2 acquisition throughout the SARS-CoV-2 pandemic — Europe PMC PMID:40830930 — Europe PMC (en), https://europepmc.org/article/MED/40830930 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_51430e40d02f (Metraipolis archive dc_51430e40d02f, sha256 32f15b1ed42768abcb5d3bfc2006350ff680b6d0566b556b9cddc94de225ecb3)
BibTeX
@misc{dc51430e40d02f,
  title = {Risk factors and effectiveness of vaccination for nosocomial SARS-CoV-2 acquisition throughout the SARS-CoV-2 pandemic — Europe PMC PMID:40830930},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40830930},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_51430e40d02f; sha256 32f15b1ed42768abcb5d3bfc2006350ff680b6d0566b556b9cddc94de225ecb3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40830930. Agents can read the archived copy with the MCP tool read_document.